Table II.
Analysis of PCR results.
Item | Tspan-1 | VEGF | E-cadherin | N-cadherin |
---|---|---|---|---|
Male | 0.4625±0.1325 | 0.3659±0.1324 | 0.1235±0.0685 | 0.4857±0.1526 |
Female | 0.4526±0.1426 | 0.3529±0.1268 | 0.1325±0.0527 | 0.4759±0.1637 |
Age, years | ||||
<62 | 0.4429±0.1258 | 0.3652±0.1127 | 0.1426±0.0737 | 0.4659±0.1527 |
≥62 | 0.4725±0.1529 | 0.3528±0.1235 | 0.1258±0.0638 | 0.4925±0.1649 |
Stage II | 0.3529±0.1123 | 0.3251±0.1426 | 0.1952±0.0859 | 0.3325±0.1323 |
Stage III | 0.5214±0.1865 | 0.3956±0.1568 | 0.0965±0.0123 | 0.5968±0.1527 |
Tumor diameter, cm | ||||
<3.3 | 0.4215±0.1238 | 0.3123±0.1257 | 0.1857±0.0785 | 0.4215±0.1538 |
≥3.3 | 0.4968±0.1857 | 0.4214±0.1869 | 0.0865±0.0232 | 0.5263±0.2123 |
VEGF, vascular endothelial growth factor.